Barclays
BENF icon

Barclays’s Beneficient BENF Stock Holding History

Barclays’s Portfolio BENF Stock Details BENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$2 – 5264
2025
Q1 		$2 Buy
+1
New +$4 ﹤0.01% 5211

Other funds holding BENF

HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays's BENF Position: Q2 2025 in Review

Barclays sold out of Beneficient (BENF) in Q2 2025, closing a stake of 1 share — an estimated $2 sold.

Barclays first reported a position in BENF in Q1 2025 and held it in 1 quarter. The position peaked at $2 in Q1 2025. 20 funds tracked by Wall St. Rank hold BENF as of Q2 2025.

  • Barclays reported no remaining Beneficient position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 1 Beneficient share in Q2 2025, an estimated $2.
  • Barclays first reported a position in Beneficient in Q1 2025 and held it in 1 quarter.
  • Barclays's Beneficient position peaked at $2 in Q1 2025.
  • 20 funds tracked by Wall St. Rank held Beneficient as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.